Mental health

What is psilocybin therapy? The psychedelic treatment revolution

Published October 25, 2024 · 8 min read · Updated April 2026

Reviewed for accuracy by licensed clinical professionals.

Psilocybin is the active compound in psychedelic mushrooms. In clinical settings, psilocybin-assisted therapy has shown remarkable results for treatment-resistant depression, addiction, and end-of-life anxiety. It has FDA Breakthrough Therapy designation.

How therapy works

Preparation sessions, a supervised 4-6 hour dosing session with trained therapists, and integration sessions afterward. The experience is a catalyst for therapeutic change, not the treatment itself.

Research results

60-80% of participants with treatment-resistant depression showed significant improvement. 80% smoking cessation at 6 months. Significant reductions in heavy drinking days for AUD.

Legal status

Schedule I federally. Oregon offers legal supervised services. Colorado is developing a framework. Clinical trials ongoing at major universities.

Important caveats

Results come from controlled clinical settings with trained therapists and screening. Self-administered psychedelics carry significant risks.

Authoritative sources

This article references guidelines from: NIDA · SAMHSA · CDC

Frequently asked questions

Does psilocybin therapy work?

Clinical trials show remarkable results for depression (60-80% improvement), smoking (80% cessation), and AUD in supervised clinical settings.

Is psilocybin therapy legal?

Not federally. Oregon offers legal supervised services. It has FDA Breakthrough Therapy designation.

Is psilocybin safe?

In supervised clinical settings with screening, it has a strong safety profile. Unsupervised use carries risks.

Disclaimer: Informational only. Not medical advice. SAMHSA: 1-800-662-4357.